Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The effect of the “exposome” on developmental brain health and cognitive outcomes
    Published on 2025-08-05
    1 year ago
  • Evenamide reverses schizophrenia-related dysfunction in a neurodevelopmental animal model
    Published on 2025-08-05
    1 year ago
  • Epigenetic manipulation of anterior insular cortex alters neural signals and cognitive control
    Published on 2025-08-03
    1 year ago
  • Parvalbumin interneurons mediate sex differences in prefrontal cortex function
    Published on 2025-08-01
    1 year ago
  • Integration of developmental and socio-cultural factors that confer risk for mental illness
    Published on 2025-07-31
    1 year ago
  • A biological phenotype of suicide attempt in adolescents with nonsuicidal self-injury: a machine-based learning approach
    Published on 2025-07-29
    1 year ago
  • Leveraging single-cell spatial transcriptomics and connectomics to resolve brain circuit function in psychiatry
    Published on 2025-07-28
    1 year ago
« Previous 1 … 53 54 55 56 57 … 143 Next »
Journal of Psychopharmacology
  • Unveiling potential adverse events associated with escitalopram oxalate: A real-world analysis based FDA adverse event reporting system database
    Published on 2024-04-28
    2 years ago
  • The trace amine-associated receptor 1 agonists – non-dopaminergic antipsychotics or covert modulators of D2 receptors?
    Published on 2024-04-24
    2 years ago
  • Exploring psychedelic-assisted therapy in the treatment of functional seizures: A review of underlying mechanisms and associated brain networks
    Published on 2024-04-24
    2 years ago
  • Influence of GABAA and GABAB receptor activation on auditory sensory gating and its association with anxiety in healthy volunteers
    Published on 2024-04-22
    2 years ago
  • Mining and analysis of security alert signals of valbenazine based on the Food and Drug Administration Adverse Event Reporting System database
    Published on 2024-04-20
    2 years ago
  • Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants
    Published on 2024-04-15
    2 years ago
  • Psychedelics and the ‘inner healer’: Myth or mechanism?
    Published on 2024-04-12
    2 years ago
« Previous 1 … 53 54 55 56 57 … 154 Next »
European Neuropsychopharmacology
  • Residual effects of medications for sleep disorders on driving performance: A systematic review and network meta-analysis of randomized controlled trials: NMA driving and hypnotics
    Published on 2024-02-24
    3 years ago
  • Does valerian work for insomnia? An umbrella review of the evidence
    Published on 2024-02-15
    3 years ago
  • Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials
    Published on 2024-02-10
    3 years ago
  • What is really different about older age bipolar disorder?
    Published on 2024-02-07
    3 years ago
  • Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controls
    Published on 2024-02-07
    3 years ago
  • Impact of genetic, sociodemographic, and clinical features on antidepressant treatment trajectories in the perinatal period
    Published on 2024-02-07
    3 years ago
  • Suicidal behavior: Not just an epiphenomenon of psychiatric illness
    Published on 2024-02-07
    3 years ago
« Previous 1 … 53 54 55 56 57 … 170 Next »

   Pharma Pub